FDA Approves Oral Utebzi Antibiotic for Complicated Urinary Tract Infections

FDA approves oral Utebzi antibiotic for complicated urinary tract infections

The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).

FDA Approves New Antibiotic for Complicated Urinary Tract Infections

For most people with urinary tract infections (UTIs) , a short course of antibiotics is the go-to treatment. But for complicated urinary tract infections — severe bacterial illnesses that are resistant to different forms of antibiotics — this may not be adequate. Now people with difficult-to-treat UTIs have a new medication option: The FDA has approved an antibiotic pill called Utebzi (tebipenem pivoxil).e60dc2a1-f33c-4a05-9b50-8e3e8e597629e1830…